一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集

Abstract

Full Text of PDF Full Text of PDF (558k)
Article in Japanese

Review

Should thoracoscopic total pleural covering be recommended to prevent the recurrence of pneumothorax associated with lymphangioleiomyomatosis?

Mie Hayashidaa,b  Yosuke Wadac  Yoshiaki Kitaguchic  Masanori Yasuoc  Masayuki Hanaokaa,c  Kuniaki Seyamaa,d  Yoshikazu Inouea,e  Koichiro Tatsumia,f 

aThe Intractable Respiratory Diseases and Pulmonary Hypertension Research Group of the Japanese Ministry of Health, Labor and Welfare
bDepartment of Internal Medicine, Division of Respiratory Medicine, Infectious Diseases and Allergy, Shinshu University Hospital
cFirst Department of Internal Medicine, Shinshu University School of Medicine
dDivision of Respiratory Medicine, Juntendo University, Faculty of Medicine and Graduate School of Medicine
eClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center
fDepartment of Respirology, Graduate School of Medicine, Chiba University

ABSTRACT

Lymphangioleiomyomatosis (LAM) is frequently associated with pneumothorax, often recurrent and intractable. The Official Clinical Practice Guidelines from the American Thoracic Society/Japanese Respiratory Society recommend performing pleurodesis when the first episode of pneumothorax occurs. Thoracoscopic total pleural covering has been reported as a new treatment for pneumothorax associated with LAM and it is therefore of clinical importance to establish the positioning of this treatment. Qualitative systematic reviews and recommendations have been created according to the Minds Handbook for Clinical Practice Guideline Development.

KEYWORDS

Lymphangioleiomyomatosis (LAM)  Pneumothorax  Total pleural covering (TPC)  Systematic review  Minds 

Received 17 Jan 2020 / Accepted 13 Feb 2020

AJRS, 9(3): 151-159, 2020

Google Scholar